Why Is American Oriental Bioengineering Resissuing Shares, Now? [View article]
I looked at AOBO back in June and decided to pass them up after AOBO filed an S3 on 6/13 stating they were planning a second offering of 15 million shares. With that announcement it was also announced that CEO Tony Liu would be selling 2 million of his personal shares.
It seems like they have sinced ammended the S3 but the outlook for the company has not changed.
AOBO is operating in a very competitive marketplace and I do not believe they have the competitive advantage to set them apart in China.
-
I looked at AOBO back in June and decided to pass them up after AOBO filed an S3 on 6/13 stating they were planning a second offering of 15 million shares. With that announcement it was also announced that CEO Tony Liu would be selling 2 million of his personal shares.
Jun 28 22:00 pm
|Rating:
0
0
All Comments by rnairb »Why Is American Oriental Bioengineering Resissuing Shares, Now? [View article]
It seems like they have sinced ammended the S3 but the outlook for the company has not changed.
AOBO is operating in a very competitive marketplace and I do not believe they have the competitive advantage to set them apart in China.